Helius Medical Technologies, Inc. (HSDT) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Seastar Medical Holding Corp.

Helius Medical Technologies, Inc.

Sharps Technology, Inc.

NeuroMetrix, Inc.

Vivos Therapeutics, Inc.

Ekso Bionics Holdings, Inc.

BioRestorative Therapies, Inc.

Creative Medical Technology Holdings, Inc.

ENDRA Life Sciences, Inc.

Aethlon Medical, Inc.

Navidea Biopharmaceuticals, Inc.

Why is Helius Medical Technologies, Inc. ?

Poor Management Efficiency with a low ROE of 0%

The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward

Poor long term growth as Operating profit has grown by an annual rate 1.57% of over the last 5 years

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -90.74%, its profits have fallen by -1551.6%

Underperformed the market in the last 1 year

Even though the market (S&P 500) has generated returns of 20.78% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -90.74% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Helius Medical Technologies, Inc. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Helius Medical Technologies, Inc.

-90.74%

0.01

4692.89%

S&P 500

20.78%

1.56

13.28%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

5.71%

EBIT Growth (5y)

1.57%

EBIT to Interest (avg)

-16.83

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.87

Sales to Capital Employed (avg)

0.21

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

44.20%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-0.52

EV to EBIT

2.92

EV to EBITDA

2.92

EV to Capital Employed

0.16

EV to Sales

-44.75

PEG Ratio

Dividend Yield

ROCE (Latest)

5.55%

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

18What is working for the Company

NET SALES(HY)

At USD 8.85 MM has Grown at 4,302.49%

PRE-TAX PROFIT(Q)

At USD -8.92 MM has Grown at 84.36%

NET PROFIT(Q)

At USD -8.92 MM has Grown at 84.36%

RAW MATERIAL COST(Y)

Fallen by -157.24% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 38.2 times

OPERATING PROFIT(Q)

Highest at USD -1.75 MM

-15What is not working for the Company

INTEREST(9M)

At USD 194.74 MM has Grown at inf%

NET PROFIT(HY)

At USD -29.32 MM has Grown at -276.44%

OPERATING CASH FLOW(Y)

Lowest at USD -17.81 MM

Here's what is working for Helius Medical Technologies, Inc.

Net Sales

At USD 8.85 MM has Grown at 4,302.49%

Year on Year (YoY)

MOJO Watch

Sales trend is very positive

Net Sales (USD MM)

Pre-Tax Profit

At USD -8.92 MM has Grown at 84.36%

over average net sales of the previous four periods of USD -56.99 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit

At USD -8.92 MM has Grown at 84.36%

over average net sales of the previous four periods of USD -56.99 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (USD MM)

Operating Profit

Highest at USD -1.75 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (USD MM)

Debtors Turnover Ratio

Highest at 38.2 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -157.24% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Helius Medical Technologies, Inc.

Interest

At USD 194.74 MM has Grown at inf%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Cash Flow

Lowest at USD -17.81 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)